Literature DB >> 12220489

An NMR view of the folding process of a CheY mutant at the residue level.

Pascal Garcia1, Luis Serrano, Manuel Rico, Marta Bruix.   

Abstract

The folding of CheY mutant F14N/V83T was studied at 75 residues by NMR. Fluorescence, NMR, and sedimentation equilibrium studies at different urea and protein concentrations reveal that the urea-induced unfolding of this CheY mutant includes an on-pathway molten globule-like intermediate that can associate off-pathway. The populations of native and denatured forms have been quantified from a series of 15N-1H HSQC spectra recorded under increasing concentrations of urea. A thermodynamic analysis of these data provides a detailed picture of the mutant's unfolding at the residue level: (1) the transition from the native state to the molten globule-like intermediate is highly cooperative, and (2) the unfolding of this state is sequential and yields another intermediate showing a collapsed N-terminal domain and an unfolded C-terminal tail. This state presents a striking similarity to the kinetic transition state of the CheY folding pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220489     DOI: 10.1016/s0969-2126(02)00804-3

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  2 in total

1.  Modulation of frustration in folding by sequence permutation.

Authors:  R Paul Nobrega; Karunesh Arora; Sagar V Kathuria; Rita Graceffa; Raul A Barrea; Liang Guo; Srinivas Chakravarthy; Osman Bilsel; Thomas C Irving; Charles L Brooks; C Robert Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

2.  Multiple nucleic acid binding sites and intrinsic disorder of severe acute respiratory syndrome coronavirus nucleocapsid protein: implications for ribonucleocapsid protein packaging.

Authors:  Chung-Ke Chang; Yen-Lan Hsu; Yuan-Hsiang Chang; Fa-An Chao; Ming-Chya Wu; Yu-Shan Huang; Chin-Kun Hu; Tai-Huang Huang
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.